Lung cancer survivors and employment: a systematic review
A partir d'une revue systématique de la littérature publiée entre 2000 et 2018 (23 articles), cette étude analyse la situation professionnelle de patients ayant survécu à un cancer du poumon
Background : The aim of this systematic review is to identify, in a comprehensive manner, the impact of lung cancer on the employment status of survivors. Methods : The Preferred Reported Items for Systematic Reviews and Meta-analyses (PRISMA) statement was used as a formal guideline. The systematic review includes scientific papers published between January 2000 and October 2018. The search strategy queried the database MEDLINE. Inclusion criteria comprised: [ 1 ] inclusion of patients diagnosed with lung cancer (LC) [ 2 ]; assessment of employment status or employment outcomes or work adjustments or return to work [ 3 ]; inclusion of scientific papers published in peer-reviewed journals [ 4 ]; inclusion of articles written either in English or in French. Literature reviews were not included. Results : A total of 642 scientific papers were retrieved. Twenty-three articles were included in the systematic review: 5 longitudinal studies and 18 cross-sectional studies. LC survivors are 2-3 times more likely to be unemployed as compared with control groups. Previous studies highlight a median duration of sickness absence increased for LC survivors compared to control groups. The strongest decline in earnings was observed among LC survivors as compared to other cancer types. Conclusions : LC is associated with a significant impact on employment of patients. The promising results of recent therapeutic strategies could lead to a better social and professional prognosis. A reduction of indirect costs is to be expected..
Lung Cancer 2019